Bank of Montreal
RUBY

Bank of Montreal’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bank of Montreal’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,477
Closed -$36K – 5284
2021
Q1 		$36K Sell
1,477
-4,036
-73% -$59K ﹤0.01% 3842
2020
Q4 		$50K Buy
5,513
+3,851
+232% +$22.9K ﹤0.01% 3944
2020
Q3 		$9K Sell
1,662
-1,194
-42% -$6.32K ﹤0.01% 4201
2020
Q2 		$18K Buy
+2,856
New +$16.9K ﹤0.01% 3905
2020
Q1 		– Sell
-4,437
Closed -$42K – 4905
2019
Q4 		$42K Buy
4,437
+1,377
+45% +$13.3K ﹤0.01% 3929
2019
Q3 		$24K Buy
3,060
+116
+4% +$1.35K ﹤0.01% 4005
2019
Q2 		$46K Buy
+2,944
New +$47.5K ﹤0.01% 3739
2019
Q1 		– Sell
-171
Closed -$3K – 4890
2018
Q4 		$3K Buy
171
+87
+104% +$1.59K ﹤0.01% 4305
2018
Q3 		$2K Buy
+84
New +$1.92K ﹤0.01% 4429

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of Montreal's RUBY Position: Q2 2021 in Review

Bank of Montreal sold out of Rubius Therapeutics, Inc (RUBY) in Q2 2021, closing a stake of 1,477 shares — an estimated $36K sold.

Bank of Montreal first reported a position in RUBY in Q3 2018 and held it in 9 quarters. The position peaked at $50K in Q4 2020. 108 funds tracked by Wall St. Rank hold RUBY as of Q2 2021.

  • Bank of Montreal reported no remaining Rubius Therapeutics, Inc position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 1,477 Rubius Therapeutics, Inc shares in Q2 2021, an estimated $36K.
  • Bank of Montreal first reported a position in Rubius Therapeutics, Inc in Q3 2018 and held it in 9 quarters.
  • Bank of Montreal's Rubius Therapeutics, Inc position peaked at $50K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.